Delivers up-to-date industry news on topics like drug approvals, product recalls, company expansions and acquisitions, market trends for all OSD forms, as well as excipients, packaging and supply chain issues. Monitors market trends in specific drug categories as well as in supplements/nutraceuticals. Provides updates on clinical trials. Includes alerts about new or upcoming regulatory issues.
The global 3D printed drugs market 3D printed drugs market is expected to reach $269.74M by 2030, according to a report by Grand View Research. The market is expected to expand at a CAGR of 15.32% from 2022 to 2030. The rising prevalence of chronic diseases, combined with the rising population of patients with dysphagia around the globe is ...
read more
The global Contraceptive Drugs market size is projected to reach $13880M by 2028, from $10620 Million in 2021, at a CAGR of 3.9% during 2022-2028, according to a report from Valuates.
read more
The Global Pharmaceutical Manufacturing Market is expected to register a CAGR of more than 11% over the forecast period, 2022-2027.
read more
The global oral solid dosage contract manufacturing market size is expected to reach $54.7B by 2030, registering a CAGR of 6.0% over the forecast period.
read more
A report by The Insight Partners estimates that the global sports nutrition market size will grow from $41.68B in 2021 to $72.17B by 2028 at a CAGR of 8.2% from 2022 to 2028.
read more
The United States Herbal Supplements Market size was estimated at $2,246.03Min 2021, $2,564.74M in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 10.62% to reach $4,116.48M by 2027, according to a report by Research & Markets.
read more
The Novasep-PharmaZell Group has announced a €7.3M investment for its Mourenx site (southwestern France), as part of a larger project supported by the "France Relance" Plan, to create a multipurpose pilot workshop within one of its production units.
read more
Societal CDMO, a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, announced that it has been selected to provide CDMO services to support the ongoing clinical development of a novel drug candidate in Europe.
read more
Health Canada has approved RINVOQ® (upadacitinib, 15 mg), the first oral, once-daily selective and reversible JAK inhibitor for the treatment of adults with active ankylosing spondylitis (AS) who have had an inadequate response to a biologic disease modifying anti-rheumatic drug (DMARD) or when use of those therapies is inadvisable.
read more
'Taste Masking and Taste Assessment Services and Technologies Market, 2022-2035 report features an extensive study of the current market landscape, offering an informed opinion on the taste masking and taste assessment services and technologies. The report, by Research & Markets, features an in-depth analysis, highlighting the diverse capabilities ...
read more
Tris Pharma announced the publication of a Phase 3 study in the Journal of Clinical Psychiatry that demonstrated that adult patients with ADHD who took DYANAVEL XR (amphetamine) tablets CII had statistically significant improvement in symptoms over patients who took placebo.
read more
The global pharmacy automation market reached a value of$ 5.4B in 2021, according to a report by Research & Markets. The report projects that the market will reach $8.6B by 2027, exhibiting a CAGR of 8.06% during 2021-2027.
read more
The multivitamins market is valued at $31.39B in 2021 and is expected to reach $48.78 Billion by 2028 with a CAGR of 6.5% over the forecast period, according to a report by Brandessence.
read more
Gilead Sciences announced results reinforcing Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, B/F/TAF) as a highly efficacious treatment option for a broad range of people with HIV, including individuals with HIV/hepatitis B (HBV) coinfection.
read more
Bausch Health Companies and its gastroenterology business Salix Pharmaceuticals announced the U.S. District Court of Delaware issued an Oral Order in the matter of Salix Pharmaceuticals, Ltd. et al v. Norwich Pharmaceuticals, Inc. regarding the infringement and validity of certain U.S. Patents protecting the composition and use of XIFAXAN® (...
read more